Systematic review with meta-analysis: the efficacy of levofloxacin triple therapy as the first- or second-line treatments of Helicobacter pylori infection

摘要

BackgroundLevofloxacin triple therapy has been used for the first-line and second-line treatment of Helicobacter pylori infection for more than 10years.